Ulipristal acetate on quality of life and sexual function of women with uterine fibromatosis

References

• Ryan G, Syrop CH, Van Voorhis BJ. Role, epidemiology, and natural history of benign uterine mass lesions. Clin Obstet Gynecol. 2005;48:312–324.
   PubMed Web of Science ®Google Scholar
• Reis FM, Bloise E, Ortiga-Carvalho TM. Hormones and pathogenesis of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:13–24.
   PubMed Web of Science ®Google Scholar
• Al-Zaghal A, Werner TJ, Høilund-Carlsen PF, et al. The detection of uterine leiomyoma (fibroid) calcifications on 18F-NaF PET/CT. Clin Nucl Med. 2018;43:e287–e288.
   PubMed Web of Science ®Google Scholar
• Fernandez H, Ardaens K, Queval I, et al. Impact of uterine fibroids on quality of life: a national cross-sectional survey. Eur J Obstet Gynecol Reprod Biol. 2018;229:32–37.
   PubMed Web of Science ®Google Scholar
• Fortin C, Flyckt R, Falcone T. Alternatives to hysterectomy: the burden of fibroids and the quality of life. Best Pract Res Clin Obstet Gynaecol. 2018;46:31–42.
   PubMed Web of Science ®Google Scholar
• Borah BJ, Nicholson WK, Bradley L, et al. The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol. 2013;209:319.e1–319.e20.
   PubMed Web of Science ®Google Scholar
• Grings AO, Lora V, Ferreira GD, et al. Protein expression of estrogen receptors α and β and aromatase in myometrium and uterine leiomyoma. Gynecol Obstet Investig. 2012;73:113–117.
   PubMed Web of Science ®Google Scholar
• Bulun SE. Uterine fibroids. N Engl J Med. 2013;369:1344–1355.
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Ishi K, Serna VA, et al. Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology. 2010;151:2433–2442.
   PubMed Web of Science ®Google Scholar
• Segars JH, Parrott EC, Nagel JD, et al. Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations. Human Reprod Update. 2014;20:309–333.
   PubMed Web of Science ®Google Scholar
• Pohl O, Howard Zobrist R, Gotteland JP. The clinical pharmacology and pharmacokinetics of ulipristal acetate for the treatment of uterine fibroids. Reprod Sci. 2015;22:476–483.
   PubMed Web of Science ®Google Scholar
• Yun BS, Seong SJ, Cha DH, et al. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist. Eur J Obstet Gynecol Reprod Biol. 2015;191:62–67.
   PubMed Web of Science ®Google Scholar
• Shin SJ, Kim J, Lee S, et al. Ulipristal acetate induces cell cycle delay and remodeling of extracellular matrix. Int J Mol Med. 2018;42:1857–1864.
   PubMed Web of Science ®Google Scholar
• Courtoy GE, Henriet P, Marbaix E, et al. Matrix Metalloproteinase activity correlates with uterine myoma volume reduction after ulipristal acetate treatment. J Clin Endocrinol Metab. 2018;103:1566–1573.
   PubMed Web of Science ®Google Scholar
• Courtoy GE, Donnez J, Ambroise J, et al. Gene expression changes in uterine myomas in response to ulipristal acetate treatment. Reprod Biomed Online. 2018;37:224–233.
   PubMed Web of Science ®Google Scholar
• Biglia N, Carinelli S, Maiorana A, et al. Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids. Drug Des Devel Ther. 2014;8:285–292.
   PubMed Web of Science ®Google Scholar
• Donnez J, Courtoy GE, Donnez O, et al. Ulipristal acetate for the management of large uterine fibroids associated with heavy bleeding: a review. Reprod Biomed Online. 2018;37:216–223.
   PubMed Web of Science ®Google Scholar
• Donnez J, Vázquez F, Tomaszewski J, PEARL III and PEARL III Extension Study Group, et al. Long-term treatment of uterine fibroids with ulipristal acetate. Fertil Steril. 2014;101:1565–1573. ;.
   PubMed Web of Science ®Google Scholar
• Soliman AM, Margolis MK, Castelli-Haley J, et al. Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey. Curr Med Res Opin. 2017;33:1971–1978.
   PubMed Web of Science ®Google Scholar
• Tushy B, Gabbert M, Weiss C, et al. Change in sexuality during ulipristal acetate treatment in women with symptomatic uterine fibroids. Eur J Obstet Gynecol Reprod Biol. 2018;228:106–110.
   PubMed Web of Science ®Google Scholar
• The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.
   PubMed Web of Science ®Google Scholar
• Wiegel MC, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005; 31:1–20.
   PubMed Web of Science ®Google Scholar
• Nieman LK, Blocker W, Nansel T, et al. Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study. Fertil Steril. 2011;95:767–772.
   PubMed Web of Science ®Google Scholar
• Powel M, Dutta D. Esmya® and the PEARL studies: a review. Womens Health (Lond). 2016;12:544–548.
   PubMedGoogle Scholar
• Simon JA, Catherino W, Segars JH, et al. Ulipristal acetate for treatment of symptomatic uterine leiomyomas: a randomized controlled trial. Obstet Gynecol. 2018;131:431–439.
   PubMed Web of Science ®Google Scholar
• Fernandez H, Schmidt T, Powell M, et al. Real word data of 1473 patients treated with ulipristal acetate for uterine fibroids: Premya study results. Eur J Obst Gynecol Reprod Biol. 2017;208:91–96.
   PubMed Web of Science ®Google Scholar
• Donnez J, Tatarchuk TF, Bouchard P, et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012;366:409–420.
   PubMed Web of Science ®Google Scholar
• Donnez J, Tomaszewski J, Vázquez F, et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med. 2012;366:421–432.
   PubMed Web of Science ®Google Scholar
• Radosa JC, Radosa CG, Mavrova R, et al. Postoperative quality of life and sexual function in premenopausal women undergoing laparoscopic myomectomy for symptomatic fibroids: a prospective observational cohort study. PLoS One. 2016;11:e0166659.
   PubMed Web of Science ®Google Scholar
• Pron G, Cohen M, Soucie J, et al. The Ontario uterine fibroid embolization trial. Part 1. Baseline patient characteristics, fibroid burden, and impact of life. Fertil Steril. 2003;79:112–119.
   PubMed Web of Science ®Google Scholar
• Donnez J, Donnez O, Matule D, et al. Long-term medical management of uterine fibroids with ulipristal acetate. Fertil Steril. 2016;105:165–173.
   PubMed Web of Science ®Google Scholar